Efficacy of coronary sinus reducer in patients with refractory angina and chronic total occlusion
Clinical Research in Cardiology · 2026-01 · 115 (1) · 69-77
DOI: 10.1007/s00392-025-02723-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Research in Cardiology, online erschienen am 19.08.2025. Verfasst von Maayan Konigstein und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Tel Aviv Sourasky Medical Center, affiliated with the Tel Aviv University School of Medicine, Tel Aviv, Israel. Maayan.konigs…. Hauptthemen laut MEDLINE: Coronary Sinus, Coronary Occlusion, Quality of Life, Angina Pectoris. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Coronary chronic total occlusion (CTO) is a common cause of refractory angina, and impaired quality of life. Coronary sinus reducer (CSR) implantation is a safe and effective therapy for patients with refractory angina. AIM: To evaluate the clinical efficacy of reducer implantation to relieve angina in patients with CTO. METHODS: Patients with refractory angina and no option for revascularization who underwent Reducer implantation between 2011 and 2023 were included. Angina symptoms, physical capacity, and quality of life were evaluated at baseline, 6 months, and 1 year following reducer implantation. Clinical outcomes were compared between patients with and without CTO. RESULTS: Overall, 262 patients (70 ± 11 years old, 24% female) underwent reducer implantation, and 131 (50%) had CTO. Among the entire population, 77% of patients had improvement of at least 1 CCS class following reducer implantation, and 42% reported improvement of ≥ 2 grades of CCS at 1 year. Median 6MWT increased from 300 m (IQR 218-382) to 358 m (IQR 275-419) 6 months following reducer implantation, and all 5 domains of the SAQ improved (p < 0.001 for all). The degree of improvement in angina severity as well as in quality of life was similar for patients with and without CTO except for better improvement in 6MWT distance among patients without CTO. Patients with CTO of the right coronary artery showed similar improvement following reducer implantation. CONCLUSIONS: Reducer implantation is similarly beneficial for patients with refractory angina due to both CTO and non-CTO lesions. Randomized prospective studies are needed to evaluate the optimal therapeutic approach in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Tel Aviv Sourasky Medical Center, affiliated with the Tel Aviv University School of Medicine, Tel Aviv, Israel. Maayan.konigstein@gmail.com.
- Cardiovascular Center, ZNA Middelheim, Antwerp, Belgium.
- Division of Cardiology, Tel Aviv Sourasky Medical Center, affiliated with the Tel Aviv University School of Medicine, Tel Aviv, Israel.
Zitieren
APA
Konigstein, M., Moroni, A., Verheye, S., Zornitzki, L., Freund, O., & Banai, S. (2026). Efficacy of coronary sinus reducer in patients with refractory angina and chronic total occlusion. Clinical Research in Cardiology, 115(1), 69-77. https://doi.org/10.1007/s00392-025-02723-3
Vancouver
Konigstein M, Moroni A, Verheye S, Zornitzki L, Freund O, Banai S. Efficacy of coronary sinus reducer in patients with refractory angina and chronic total occlusion. Clinical Research in Cardiology. 2026;115(1):69-77. doi:10.1007/s00392-025-02723-3
BibTeX
@article{Konigstein2026,
author = {Konigstein, Maayan and Moroni, Alice and Verheye, Stefan and Zornitzki, Lior and Freund, Ophir and Banai, Shmuel},
title = {Efficacy of coronary sinus reducer in patients with refractory angina and chronic total occlusion},
journal = {Clinical Research in Cardiology},
year = {2026},
volume = {115},
number = {1},
pages = {69--77},
doi = {10.1007/s00392-025-02723-3}
}
EUVIMED